STAAR Surgical Company

Total Valuation

STAAR Surgical Company carries a market capitalization of 1.07B, placing it among publicly traded companies globally. Its enterprise value stands at 1.29B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

STAAR Surgical Company currently has 50.12M shares outstanding.

Valuation Ratios

STAAR Surgical Company trades at a trailing price-to-earnings ratio of 372.96. The price-to-sales ratio is 4.22, and the price-to-book ratio stands at 3.94.

Enterprise Valuation

On an enterprise value basis, STAAR Surgical Company trades at an EV/EBITDA multiple of 25.45 and an EV/FCF ratio of 5,275.43. The EV/Sales ratio of 3.81 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 31.52 provides insight into valuation relative to core operating earnings.

Financial Position

STAAR Surgical Company maintains a current ratio of 4.66, meaning it holds 4.7x the short-term assets needed to cover near-term liabilities.

Financial Efficiency

STAAR Surgical Company posts a return on equity of 1.09 and a return on invested capital of 2.32.

Taxes

Over the trailing twelve months, STAAR Surgical Company has paid 13.54M in income taxes, reflecting an effective tax rate of 77.91.

Stock Price Statistics

STAAR Surgical Company's stock has declined approximately -15.99526% over the past 52 weeks. The 50-day moving average sits at 22.72, while the 200-day moving average is 23.56.

Income Statement

Over the trailing twelve months, STAAR Surgical Company generated 339.59M in revenue and converted that into 3.84M in net income, yielding earnings per share of 0.08. EBITDA reached 50.78M, while operating income came in at 41.01M.

Balance Sheet

STAAR Surgical Company holds 181.49M in cash and equivalents against 35.94M in total debt, resulting in a net debt position of -148.58M. Total book value stands at 365.40M, with working capital of 268.96M providing operational flexibility.

Cash Flow

STAAR Surgical Company produced -3.25M in operating cash flow over the past twelve months. After subtracting -3.50M in capital expenditures, free cash flow totaled -6.75M - equivalent to -0.14 per share.

Margins

STAAR Surgical Company operates with a gross margin of 76.62, reflecting its pricing power and cost economics. The operating margin of 12.08 and net profit margin of 1.13 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

STAAR Surgical Company's most recent stock split took place on May 18, 1992 with a 2:1 split ratio.

Scores

STAAR Surgical Company posts an Altman Z-Score of 9.24, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.